{"entity":{"type":"insider","cik":"0001452635","url":"/insider/0001452635","json_url":"/insider/0001452635.json","name":"Babu Yarlagadda S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":15,"first":"2009-09-24","last":"2022-11-16","span_basis":"filed_date"},"name_variants":[{"name":"Babu Yarlagadda S","source":"filing","n_filings":15,"first_seen":"2009-09-24","last_seen":"2022-11-16"}],"transactions":[{"id":6578110,"accession":"0001127602-22-025761","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-22-025761","line_url":"/filing/0001127602-22-025761#line-3","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001452635","owner_name":"Babu Yarlagadda S","owner_display_name":"Babu Yarlagadda S","owner_url":"/insider/0001452635","role":"Officer (Chief Discovery Officer)","role_mark":"O","role_mark_label":"Officer (Chief Discovery Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Discovery Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31515.0,"shares_display":"31,515","price_per_share":13.88,"price_display":"13.88","price_state":"stated","total_value":437428.2,"total_display":"437,428.20","total_whole":"437,428","shares_owned_after":298541.0,"shares_owned_after_display":"298,541","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-14","filed_date":"2022-11-16","scope":"insider"},{"id":6538615,"accession":"0001127602-22-008780","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-008780","line_url":"/filing/0001127602-22-008780#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001452635","owner_name":"Babu Yarlagadda S","owner_display_name":"Babu Yarlagadda S","owner_url":"/insider/0001452635","role":"Officer (Chief Discovery Officer)","role_mark":"O","role_mark_label":"Officer (Chief Discovery Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Discovery Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":17.16,"price_display":"17.16","price_state":"stated","total_value":343200.0,"total_display":"343,200.00","total_whole":"343,200","shares_owned_after":230056.0,"shares_owned_after_display":"230,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-07","filed_date":"2022-03-09","scope":"insider"},{"id":5541756,"accession":"0001127602-21-030610","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-030610","line_url":"/filing/0001127602-21-030610#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001452635","owner_name":"Babu Yarlagadda S","owner_display_name":"Babu Yarlagadda S","owner_url":"/insider/0001452635","role":"Officer (Chief Discovery Officer)","role_mark":"O","role_mark_label":"Officer (Chief Discovery Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Discovery Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30100.0,"shares_display":"30,100","price_per_share":12.2,"price_display":"12.20","price_state":"stated","total_value":367220.0,"total_display":"367,220.00","total_whole":"367,220","shares_owned_after":215056.0,"shares_owned_after_display":"215,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-07","filed_date":"2021-12-09","scope":"insider"},{"id":8447305,"accession":"0001127602-19-033004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-19-033004","line_url":"/filing/0001127602-19-033004#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001452635","owner_name":"Babu Yarlagadda S","owner_display_name":"Babu Yarlagadda S","owner_url":"/insider/0001452635","role":"Officer (Senior VP - Drug Discovery)","role_mark":"O","role_mark_label":"Officer (Senior VP - Drug Discovery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - Drug Discovery","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.45,"price_display":"1.45","price_state":"stated","total_value":36250.0,"total_display":"36,250.00","total_whole":"36,250","shares_owned_after":155587.0,"shares_owned_after_display":"155,587","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-18","scope":"insider"},{"id":2147514,"accession":"0001127602-16-061295","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-16-061295","line_url":"/filing/0001127602-16-061295#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001452635","owner_name":"Babu Yarlagadda S","owner_display_name":"Babu Yarlagadda S","owner_url":"/insider/0001452635","role":"Officer (Senior VP - Drug Discovery)","role_mark":"O","role_mark_label":"Officer (Senior VP - Drug Discovery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - Drug Discovery","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":4.06,"price_display":"4.06","price_state":"stated","total_value":121800.0,"total_display":"121,800.00","total_whole":"121,800","shares_owned_after":111428.0,"shares_owned_after_display":"111,428","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-25","filed_date":"2016-08-29","scope":"insider"},{"id":8091971,"accession":"0001127602-15-012201","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-15-012201","line_url":"/filing/0001127602-15-012201#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001452635","owner_name":"Babu Yarlagadda S","owner_display_name":"Babu Yarlagadda S","owner_url":"/insider/0001452635","role":"Officer (Senior VP - Drug Discovery)","role_mark":"O","role_mark_label":"Officer (Senior VP - Drug Discovery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - Drug Discovery","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12105.0,"shares_display":"12,105","price_per_share":10.16,"price_display":"10.16","price_state":"stated","total_value":122986.8,"total_display":"122,986.80","total_whole":"122,987","shares_owned_after":148697.0,"shares_owned_after_display":"148,697","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-19","filed_date":"2015-03-20","scope":"insider"},{"id":8173797,"accession":"0001127602-15-010426","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-15-010426","line_url":"/filing/0001127602-15-010426#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001452635","owner_name":"Babu Yarlagadda S","owner_display_name":"Babu Yarlagadda S","owner_url":"/insider/0001452635","role":"Officer (Senior VP - Drug Discovery)","role_mark":"O","role_mark_label":"Officer (Senior VP - Drug Discovery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - Drug Discovery","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37400.0,"shares_display":"37,400","price_per_share":10.59,"price_display":"10.59","price_state":"stated","total_value":396066.0,"total_display":"396,066.00","total_whole":"396,066","shares_owned_after":160802.0,"shares_owned_after_display":"160,802","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-05","filed_date":"2015-03-06","scope":"insider"},{"id":8201340,"accession":"0001127602-15-010303","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-15-010303","line_url":"/filing/0001127602-15-010303#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001452635","owner_name":"Babu Yarlagadda S","owner_display_name":"Babu Yarlagadda S","owner_url":"/insider/0001452635","role":"Officer (Senior VP - Drug Discovery)","role_mark":"O","role_mark_label":"Officer (Senior VP - Drug Discovery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - Drug Discovery","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10495.0,"shares_display":"10,495","price_per_share":10.5,"price_display":"10.50","price_state":"stated","total_value":110197.5,"total_display":"110,197.50","total_whole":"110,198","shares_owned_after":198202.0,"shares_owned_after_display":"198,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-04","filed_date":"2015-03-05","scope":"insider"},{"id":7045448,"accession":"0001127602-14-010714","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-14-010714","line_url":"/filing/0001127602-14-010714#line-5","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001452635","owner_name":"Babu Yarlagadda S","owner_display_name":"Babu Yarlagadda S","owner_url":"/insider/0001452635","role":"Officer (Senior VP - Drug Discovery)","role_mark":"O","role_mark_label":"Officer (Senior VP - Drug Discovery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP - Drug Discovery","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40642.0,"shares_display":"40,642","price_per_share":12.57,"price_display":"12.57","price_state":"stated","total_value":510869.94,"total_display":"510,869.94","total_whole":"510,870","shares_owned_after":208195.0,"shares_owned_after_display":"208,195","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-04","filed_date":"2014-03-07","scope":"insider"},{"id":2548184,"accession":"0001127602-12-009466","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-12-009466","line_url":"/filing/0001127602-12-009466#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001452635","owner_name":"Babu Yarlagadda S","owner_display_name":"Babu Yarlagadda S","owner_url":"/insider/0001452635","role":"Officer (VP Drug Discovery)","role_mark":"O","role_mark_label":"Officer (VP Drug Discovery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Drug Discovery","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":837.0,"shares_display":"837","price_per_share":4.78,"price_display":"4.78","price_state":"stated","total_value":4000.86,"total_display":"4,000.86","total_whole":"4,001","shares_owned_after":125769.0,"shares_owned_after_display":"125,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-02","filed_date":"2012-03-05","scope":"insider"},{"id":2484508,"accession":"0001127602-12-007673","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-12-007673","line_url":"/filing/0001127602-12-007673#line-4","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001452635","owner_name":"Babu Yarlagadda S","owner_display_name":"Babu Yarlagadda S","owner_url":"/insider/0001452635","role":"Officer (VP Drug Discovery)","role_mark":"O","role_mark_label":"Officer (VP Drug Discovery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Drug Discovery","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30912.0,"shares_display":"30,912","price_per_share":4.22,"price_display":"4.22","price_state":"stated","total_value":130448.64,"total_display":"130,448.64","total_whole":"130,449","shares_owned_after":52738.0,"shares_owned_after_display":"52,738","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-22","filed_date":"2012-02-23","scope":"insider"},{"id":5642238,"accession":"0001127602-09-021128","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-09-021128","line_url":"/filing/0001127602-09-021128#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001452635","owner_name":"Babu Yarlagadda S","owner_display_name":"Babu Yarlagadda S","owner_url":"/insider/0001452635","role":"Officer (VP Drug Discovery)","role_mark":"O","role_mark_label":"Officer (VP Drug Discovery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Drug Discovery","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6400.0,"shares_display":"6,400","price_per_share":10.8472,"price_display":"10.85","price_state":"stated","total_value":69422.08,"total_display":"69,422.08","total_whole":"69,422","shares_owned_after":39362.0,"shares_owned_after_display":"39,362","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-26","filed_date":"2009-10-28","scope":"insider"},{"id":5842267,"accession":"0001127602-09-021017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-09-021017","line_url":"/filing/0001127602-09-021017#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001452635","owner_name":"Babu Yarlagadda S","owner_display_name":"Babu Yarlagadda S","owner_url":"/insider/0001452635","role":"Officer (VP Drug Discovery)","role_mark":"O","role_mark_label":"Officer (VP Drug Discovery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Drug Discovery","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":2000.0,"total_display":"2,000.00","total_whole":"2,000","shares_owned_after":45762.0,"shares_owned_after_display":"45,762","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-21","filed_date":"2009-10-22","scope":"insider"},{"id":5681145,"accession":"0001127602-09-020996","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-09-020996","line_url":"/filing/0001127602-09-020996#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001452635","owner_name":"Babu Yarlagadda S","owner_display_name":"Babu Yarlagadda S","owner_url":"/insider/0001452635","role":"Officer (VP Drug Discovery)","role_mark":"O","role_mark_label":"Officer (VP Drug Discovery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Drug Discovery","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3400.0,"shares_display":"3,400","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":34000.0,"total_display":"34,000.00","total_whole":"34,000","shares_owned_after":45962.0,"shares_owned_after_display":"45,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-20","filed_date":"2009-10-21","scope":"insider"},{"id":5737096,"accession":"0001127602-09-019441","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-09-019441","line_url":"/filing/0001127602-09-019441#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001452635","owner_name":"Babu Yarlagadda S","owner_display_name":"Babu Yarlagadda S","owner_url":"/insider/0001452635","role":"Officer (VP Drug Discovery)","role_mark":"O","role_mark_label":"Officer (VP Drug Discovery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Drug Discovery","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":9.136,"price_display":"9.14","price_state":"stated","total_value":182720.0,"total_display":"182,720.00","total_whole":"182,720","shares_owned_after":49362.0,"shares_owned_after_display":"49,362","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-23","filed_date":"2009-09-24","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000882796","name":"BIOCRYST PHARMACEUTICALS INC","url":"/issuer/0000882796","role":"Officer (Chief Discovery Officer)","n_filings":15,"first_seen":"2009-09-24","last_seen":"2022-11-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001452635","retrieved_at":"2026-08-24T13:10:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}